Stan

Okay.

So

Has there been any... Okay, so all these data points, comment on them a little bit.

Are we seeing environmental things?

What's going on here?

Good point.

Good point.

Right, right.

So, all right.

You mentioned at the very top of the show that, you know, we're dealing with kind of an equity issue here.

So we're seeing populations, okay, putting on our public health hats for a minute.

We're seeing populations that are, you know,

higher risk so um help our audience understand why is the black community at a higher risk why is the hispanic community why are women at higher risk has there been any indications or any research that's done that that might shed some light on this um

We'll get that on our website.

So, you know, I'd be remiss not to, I guess, bring in a little bit of the politics of the day, unfortunately.

So I saved this from the Minneapolis Star Tribune, and it came out on Friday, March 21st, a couple days ago.

blocked funding stalls key Alzheimer's drugs.

Now, as I read through our background research, right now there isn't a treatment or there isn't a particular drug, but if we're stalling these things, truly if we're stalling these things, like Alzheimer's drug treatment,

It's like, where are we headed then?

So you, you, you, you understand my angst.